Coffee Drinkers Have Much Lower Risk of Bowel Cancer Recurrence, Study Finds

Research has found that people with bowel cancer who drink two to four cups of coffee a day are much less likely to see their disease come back and are also much less likely to die from any cause, suggesting coffee helps those diagnosed with the UK’s second biggest cancer killer. Experts believe the findings are “promising” and speculate that, if other studies show the same effect, the 43,000 Britons a year diagnosed with bowel cancer may be encouraged to drink coffee. The disease claims about 16,500 lives a year – 45 a day.

A study of 1,719 bowel cancer patients in the Netherlands by Dutch and British researchers found that those who drank at least two cups of coffee had a lower risk of the disease recurring. The effect was dose dependent – those who drank the most saw their risk fall the most. Patients who had at least five cups a day were 32% less likely than those who drank fewer than two cups to see their bowel cancer return.

Higher levels of coffee consumption also appeared to be closely linked to someone’s chances of surviving. Those who drank at least two cups daily had a lower risk of dying compared with those who did not. And, as with the risk of recurrence, those who had at least five cups saw their likelihood of dying fall the most – by 29%.

People in the UK drink an estimated 95m cups of coffee a day. The research team leader, Dr Ellen Kampman, a professor of nutrition and disease at Wageningen University in the Netherlands, said the disease returned in one in five people diagnosed with it and could be fatal. However, she stressed the team had found a strong association between regular consumption of coffee and the disease rather than a causal relationship between them.

The study is the latest to show that coffee reduces cancer risk. There is already strong evidence that it lowers the risk of liver and womb cancers, as well as mouth, pharynx, larynx, and skin cancers. It is also already associated with a lower risk of developing bowel cancer.

Read More @ The Guardian

Suggested Reading